vimarsana.com
Home
Live Updates
Boehringer Ingelheim Venture Fund GmbH, Novo Holdings REPAIR Impact Fund and Evotec SE complete lead Series A investment in Centauri Therapeutics Limited : vimarsana.com
Boehringer Ingelheim Venture Fund GmbH, Novo Holdings REPAIR Impact Fund and Evotec SE complete lead Series A investment in Centauri Therapeutics Limited
Boehringer Ingelheim Venture Fund GmbH, Novo Holdings REPAIR Impact Fund and Evotec SE complete lead Series A investment in Centauri Therapeutics Limited
Related Keywords
Ingelheim ,
Rheinland Pfalz ,
Germany ,
Hamburg ,
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Copenhagen ,
Køavn ,
Denmark ,
London ,
City Of ,
Kenny Walker Durrant ,
Tim Worden ,
Sophie Mcgrath ,
Anjlee Sakaria ,
Heidi Fitchett ,
Lucy Sharples ,
Curtis Mccluskey ,
Megan Gibson ,
Cambridge Life Sciences ,
Boehringer Ingelheim Corporation ,
Impact Fund Novo ,
Infective Resistance Impact Fund ,
Boehringer Ingelheim Venture Fund Gmb ,
Novo Nordisk Foundation ,
Centauri Therapeutics Limited ,
Novo Holdings ,
Boehringer Ingelheim Venture Fund Gmbh ,
Centauri Therapeutic ,
Boehringer Ingelheim ,
Novo Nordisk ,
Anti Infective Resistance ,
Impact Fund ,
Georgia Powell ,
Ovo Holdings Repair Impact Fund And Evotec Se Complete Lead Seriesa Investment In Centauri Therapeutics Limited ,
vimarsana.com © 2020. All Rights Reserved.